Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-17-026304

Chairman and CEO acquired 100,000 shares (grant or award)

  • Chairman and CEO gave up 13,575 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KAZIMI A J Chairman and CEO 2017-04-07 Grant or award +100,000 $6.45 $645,000 5,858,845 D
KAZIMI A J Chairman and CEO 2017-04-07 Shares withheld for taxes −13,575 $6.45 $87,559 5,845,270 D
Loading xslF345X03/doc4.xml…